
Emily M Ko MD
Gynecologic Oncology
Professor, Obstetrics & Gynecology, Perelman School of Medicine
Join to view full profile
800 Walnut Street10th FloorPhiladelphia, PA 19107
Phone+1 215-829-2345
Dr. Ko is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Emily Ko is board certified in Gynecologic Oncology and Obstetrics and Gynecology, who currently serves as Professor of Gynecologic Oncology at Pennsylvania Hospital and Hospital of the University of Pennsylvania. She serves as Medical Director of the Pennsylvania Hospital Abramson Cancer Center. Located in Philadelphia, Dr. Ko has a subspecialty in Gynecologic Oncology. Her education includes a Residency at Harvard Medical School Brigham and Women's Hospital and Massachusetts General Hospital Combined OBGYN Residency, a medical degree from University of Massachusetts Medical School, a Fellowship in Gynecologic Oncology at University of North Carolina Hospitals, and an MSCR in Epidemiology from University of North Carolina Gillings School of Public Health. Dr. Ko's expertise spans surgical and medical management of all gynecologic cancers and pre-cancers as well as complex pelvic surgery. She is a prominent scholar in populations sciences and health services research as well as clinical trials with numerous publications in prestigious journals. She has conducted significant clinical trials and is well-respected in her field, as evidenced by her leadership roles in professional organizations and several honors and awards.
Education & Training
University of North Carolina HospitalsFellowship, Gynecologic Oncology, 2012
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General HospitalResidency, Obstetrics and Gynecology, 2005 - 2009
University of Massachusetts Medical SchoolClass of 2005
University of North Carolina Gillings School of Public HealthMSCR, Epidemiology
Certifications & Licensure
NJ State Medical License 2017 - 2027
PA State Medical License 2013 - 2026
NC State Medical License 2009 - 2013
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
Clinical Trials
Publications & Presentations
PubMed
- Evaluating a patient ambassador program to improve clinical trial knowledge and intent to discuss gynecologic oncology trials.Emily M Ko, Christine Pae, Lakeisha Mulugeta-Gordon, Destiny Uwawaike, Katie Elkins
Gynecologic Oncology. 2026-09-01 - Associations between molecular classification and response to intra-uterine levonorgestrel device therapy in patients with medically managed endometrial cancer and end...Angela Nolin, Morgan D Brown, Samantha M Thomas, Kyle C Strickland, Sarah Bean
International Journal of Gynecological Cancer. 2026-08-01 - MLH1 promoter hypermethylation and associations with survival outcomes: A real-world endometrial cancer molecularly targeted therapy consortium cohort study.Lindsay E Borden, Casey M Cosgrove, Christina R Washington, Samantha M Thomas, Paulina J Haight
Gynecologic Oncology. 2026-08-01
Journal Articles
- Survival Following Minimally Invasive Radical Hysterectomy for Patients with Cervical Carcinoma and Tumor Size Less Than or Equal to 2 CmBenjamin Albright, Emily M Ko, American Journal of Obstetrics and Gynecology
- Trends in the Surgical Management of Malignant Ovarian Germ-Cell TumorsSpyridon A Mastroyannis, Emily M Ko, Gynecologic Oncology
Press Mentions
Anti-Inflammatory Agents May Have Role in COVID-19 PneumoniaOctober 25th, 2022
Blood Test Shows Promise in More Accurate Detection of Ovarian CancerJune 15th, 2022
Gynecologic Cancer Survival Impacted by RaceMarch 15th, 2022
Professional Memberships
- Fellow
Other Languages
- Chinese (Mandarin), Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: